Stockreport

Heron Announces Positive Topline Results From Pivotal Phase 3 Clinical Trials of HTX-011 in Bunionectomy and Hernia Repair

Heron Therapeutics, Inc.  (HRTX) 
Last heron therapeutics, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: herontherapeutics.gcs-web.com/investor-home
PDF - HTX-011 Achieved All Primary and Key Secondary Endpoints - - HTX-011 Produced Statistically Significant Reductions in Both Pain Intensity and N [Read more]